Projects
-
Disrupción de enhancers: la nueva generación de terapia epigenética en el sarcoma de Ewing
- Leader
- Jaume Mora Graupera, Sara Sánchez Molina
- Announcement
- Proyectos de I+D+I en Salud
- Code
- PI24/00804
- Starting date
- 2025
- End date
- 2027
- Funded by
- Instituto de Salud Carlos III (ISCIII)
-
Evaluation of the effects of Oryzon Genomics proprietary compounds on pediatric patient tumors
- Leader
- Jaume Mora Graupera
- Announcement
- Conveni
- Code
- PCP00325
- Starting date
- 2021
- End date
- 2022
- Funded by
- Oryzon Genomics S.A.
-
Rabdomiosarcoma
- Leader
- Jaume Mora Graupera
- Code
- PFNR0069
- Starting date
- 2015
- End date
- 3000
- Funded by
- Clientes Diversos
